| Immunotherapy: an alternative promising therapeutic approach against cancers SL Gupta, S Basu, V Soni, RK Jaiswal Molecular Biology Reports, 1-11, 2022 | 37 | 2022 |
| A self-sustaining layer of early-life-origin B cells drives steady-state IgA responses in the adult gut S Vergani, KG Muleta, C Da Silva, A Doyle, TA Kristiansen, S Sodini, ... Immunity, 2022 | 31 | 2022 |
| Neutralizing antibody: a savior in the Covid-19 disease SL Gupta, RK Jaiswal Molecular biology reports 49 (3), 2465-2474, 2022 | 19 | 2022 |
| B-cell-based immunotherapy: A promising new alternative SL Gupta, N Khan, S Basu, V Soni Vaccines 10 (6), 879, 2022 | 17 | 2022 |
| Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults SL Gupta, G Mantus, KE Manning, M Ellis, M Patel, CR Ciric, A Lu, ... Journal of Virology, e00582-22, 2022 | 16 | 2022 |
| CD73 expression identifies a subset of IgM+ antigen‐experienced cells with memory attributes that is T cell and CD40 signalling dependent L D'Souza, SL Gupta, V Bal, S Rath, A George Immunology 152 (4), 602-612, 2017 | 13 | 2017 |
| Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters CJ Field, TA Heinly, DR Patel, DG Sim, E Luley, SL Gupta, TH Vanderford, ... Emerging microbes & infections 11 (1), 1103-1114, 2022 | 12 | 2022 |
| Children’s SARS-CoV-2 infection and their vaccination SL Gupta, R Tyagi, A Dhar, N Oswal, A Khandelwal, RK Jaiswal Vaccines 11 (2), 418, 2023 | 6 | 2023 |
| An assessment of the bivalent vaccine as a second booster for COVID-19 SL Gupta, RK Jaiswal Vaccines 11 (1), 79, 2022 | 6 | 2022 |
| Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage SL Gupta, RK Jaiswal Molecular Biology Reports 49 (10), 10137-10140, 2022 | 5 | 2022 |
| An assessment of the strategy and status of COVID-19 vaccination in India SL Gupta, S Goswami, A Anand, N Naman, P Kumari, P Sharma, ... Immunologic Research 71 (4), 565-577, 2023 | 4 | 2023 |
| An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination JM Carreño, A Raskin, G Singh, J Tcheou, H Kawabata, C Gleason, ... Science Translational Medicine 15 (683), eabo2847, 2023 | 4 | 2023 |
| Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2 A Dhar, SL Gupta, P Saini, K Sinha, A Khandelwal, R Tyagi, A Singh, ... Immunologic Research 72 (1), 14-33, 2024 | 2 | 2024 |
| IgA determines bacterial composition in the gut S Gupta, SL Gupta, A Singh, N Oswal, V Bal, S Rath, A George, S Basu Crohn's & Colitis 360 5 (3), otad030, 2023 | 2 | 2023 |
| Smart nanosensors in healthcare recent developments and applications SL Gupta, S Basu Nanosensors for Futuristic Smart and Intelligent Healthcare Systems, 3-18, 2022 | 2 | 2022 |
| Role of Immunoglobulin A in COVID-19 and Influenza Infections R Tyagi, S Basu, A Dhar, S Gupta, SL Gupta, RK Jaiswal Vaccines 11 (11), 1647, 2023 | 1 | 2023 |
| Genomic surveillance of bacterial pathogens: expanding horizons V Soni, AS Akhade, C Bhattacharya, Y Chawla, Z Bukhari, SL Gupta, ... Genomic Surveillance and Pandemic Preparedness, 71-117, 2023 | 1 | 2023 |
| Robust antibody responses in children after Pfizer vaccination SL Gupta, EJ Anderson, CA Rostad, MS Suthar, J Wrammert The Journal of Immunology 208 (1_Supplement), 65.05-65.05, 2022 | | 2022 |
Rishi JaiswalSenior reserach ScientistVerified email at jnu.ac.in
